| | 
Part, Chapter, Paragraph
1 I, 2. 10. 4(12)| Westmenister Healthcare NHS Trust, K. Robertson Ref. “Coding
2 I, 3. 4 | E, Liefbroer A, Henkens K (2001): De timing van het
3 I, 3. 4 | Esveldt, I., G. Beets, K. Henkens, A. Liefbroer &
4 II, 4. 3 | References~ ~Anderson R, Kochanek K, et al. (1997): Report of
5 II, 5. 2. 7 | 1588-1592.~Daviglus ML, Liu K, Pirzada A, Yan LL, Garside
6 II, 5. 2. 7 | Ferrario M, Sans S, Kuulasmaa K, for the WHO MONICA Project (
7 II, 5. 2. 7 | J 27: 107-113.~Kuulasmaa K, Tunstall-Pedoe H, Dobson
8 II, 5. 2. 7 | London.~Pisa Z, Uemura K (1982): Trends of mortality
9 II, 5. 2. 7 | M, Tuomilehto J, Asplund K, for the WHO MONICA Project (
10 II, 5. 2. 7 | Tolonen H, Mahonen M, Asplund K, rastenyte D, Kuulasma K,
11 II, 5. 2. 7 | K, rastenyte D, Kuulasma K, Vanuzzo D, Tuomilehto J
12 II, 5. 2. 7 | Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski
13 II, 5. 2. 7 | Lancet 355:688-700~Uemura K, Pisa Z (1988): Trends in
14 II, 5. 4. 8 | 271-6~Beck, P, Battlogg, K, Gfrerer, R, Trajanoski,
15 II, 5. 4. 8 | Ottosen P, Borch-Johnsen K (2008); on behalf of the
16 II, 5. 5.Int(18)| Makino M, Tsuboi K, Dennerstein L.(2004): Prevalence
17 II, 5. 5. 1 | Kessler R, Nelson C, McGonagle K, Liu G (1996): Comorbidity
18 II, 5. 5. 1 | 330-41.~ ~Värnik A, Kölves K, van der Feltz-Cornelius
19 II, 5. 5. 3 | Berkman, N. D.; Lohr, K. N.; Bulik, C. M. (2007):
20 II, 5. 5. 3 | Gilbert CC, Bergman P, Widhalm K, Manios Y, Breidenasse C,
21 II, 5. 5. 3 | No. 4, 351-357.~Harper K, Sperry S, Thompson JK (
22 II, 5. 5. 3 | Misra M, Aggarwal A Miller, K.K, Almazan, C, Worley, M,.
23 II, 5. 5. 3 | M, Aggarwal A Miller, K.K, Almazan, C, Worley, M,.
24 II, 5. 5. 3 | 77.~Andrews G, Sandersson K, Corry J, Issakidis C, Lapsley
25 II, 5. 5. 3 | 46:549-55.~Demyttenaere K, Bruffaerts R, Posada-Villa
26 II, 5. 5. 3 | BM, Isacson D, Bingefors K, Widerlöv B (2007): Mortality
27 II, 5. 5. 3 | 33.~Häfner H and Maurer K (2006): Early detection
28 II, 5. 5. 3 | 130-8.~Häfner H, Maurer K, Ruhrmann S, Bechdolf A,
29 II, 5. 5. 3 | Stiegler M, Rummel C, Wahlbeck K, Kissling W (2006): Call
30 II, 5. 5. 3 | Tuori T, Gissler M, Wahlbeck K), Section B, p. 257-333,
31 II, 5. 5. 3 | Court et al., 1996 (*)~U.K. ~All ages ~GP files~? ~
32 II, 5. 5. 3 | Pond et al., 1960 (*)~U.K. ~Children 4-20 years ~MR
33 II, 5. 5. 3 | a study made in Wales, U.K., a strong independent correlation
34 II, 5. 5. 3 | 6~Nilsson et al, 1997~U.K.~GP/MF~Incident cohort~149~
35 II, 5. 5. 3 | 13.~Gaitatzis A, Carroll K, Majeed A, Sander JW (2004):
36 II, 5. 5. 3 | Psychiatry 32:115-122.~Bencsik K, Rajda C, Füvesi J, et al (
37 II, 5. 5. 3 | In: Firnhaber W, Lauer K (eds): Multiple Sclerosis
38 II, 5. 5. 3 | Koch-Henriksen N, Hyllested K (1994): Survival of patients
39 II, 5. 5. 3 | 389.~Firnhaber W, Lauer K (eds) (1994): Multiple Sclerosis
40 II, 5. 5. 3 | 265.~Fox-Rushby JA, Hanson K (2001): Calculating and
41 II, 5. 5. 3 | Neurol 53:793-798.~Gross K, Kokk A, Kaasik AE (1993):
42 II, 5. 5. 3 | Koch-Henriksen N, Hyllested K (1988): Epidemiology of
43 II, 5. 5. 3 | Brønnum-Hansen H, Hyllested K (1992): Incidence of multiple
44 II, 5. 5. 3 | In: Firnhaber W, Lauer K (eds): Multiple Sclerosis
45 II, 5. 5. 3 | In: Firnhaber W, Lauer K (eds): Multiple Sclerosis
46 II, 5. 5. 3 | Milanov I, Georgiev D, Kmetska K, Jordanova L, Topalov N (
47 II, 5. 5. 3 | In: Firnhaber W, Lauer K (eds): Multiple Sclerosis
48 II, 5. 5. 3 | 575-585.~Prange AJA, Lauer K, Poser S et al (1986): Epidemiological
49 II, 5. 5. 3 | Larsen JP, Tandberg E, Laake K (2000): Predictors of nursing
50 II, 5. 5. 3 | KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM,
51 II, 5. 5. 3 | Lai BC, Marion SA, Teschke K, Tsui JK (2002): Occupational
52 II, 5. 5. 3 | von Campenhausen S, Berger K, Koehne-Volland R, Rieke
53 II, 5. 5. 3 | Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel
54 II, 5. 5. 3 | Oertel W, Siebert U, Berger K, Dodel R (2005): Prevalence
55 II, 5. 5. 3 | 473-490.~Whetten-Goldstein K, Sloan F, Kulas E, Cutson
56 II, 5. 6. 6 | G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald
57 II, 5. 6. 6 | S, Herrstrom P, Hogstrom K, Petersson IF, Svensson
58 II, 5. 6. 6 | JM, Klareskog L, Machold K, Martin-Mola E, Nielsen
59 II, 5. 6. 6 | Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley
60 II, 5. 6. 6 | Lock C, Allgar V, Jones K, Marples G, Chandler C,
61 II, 5. 6. 6 | 1141~Merx H, Dreinhofer K, Schrader P, Sturmer T,
62 II, 5. 6. 6 | 555-558~Palmer KT, Walsh K, Bendall H, Cooper C, Coggon
63 II, 5. 6. 6 | Elsevier,~Woolf AD, Akesson K (2003): Preventing fractures
64 II, 5. 6. 6 | 56~Woolf AD and Akesson K (2006): The Patient with
65 II, 5. 7. 7 | 432-44.~Baigent C, Burbury K, Wheeler D (2000): Premature
66 II, 5. 7. 7 | JW, Spruill M, Reynolds K, et al (2005) Prevalence
67 II, 5. 7. 7 | 2275-84.~Hallan SI, Dahl K, Oien CM, Grootendorst DC,
68 II, 5. 7. 7 | National Kidney Foundation. K/D The seventh report of
69 II, 5. 7. 7 | National Kidney Foundation. K/DOQI clinical practice guidelines
70 II, 5. 7. 7 | National Kidney Foundation. K/DOQI clinical practice guidelines
71 II, 5. 7. 7 | National Kidney Foundation. K/DOQI clinical practice guidelines
72 II, 5. 7. 7 | National Kidney Foundation. K/DOQI clinical practice guidelines
73 II, 5. 7. 7 | Jager KJ, Dekker FW, Simpson K, et al (2003): Trends in
74 II, 5. 8. 7 | P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz
75 II, 5. 8. 7 | Milton D, Schwartz D, Toren K, Viegi G (2003): American
76 II, 5. 8. 7 | 797~ ~Bergdahl IA, Toren K, Eriksson K, Hedlund U,
77 II, 5. 8. 7 | Bergdahl IA, Toren K, Eriksson K, Hedlund U, Nilsson T, Flodin
78 II, 5. 8. 7 | Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia
79 II, 5. 8. 7 | 123: 1684-1692.~ ~Horton K (2008): The use of telecare
80 II, 5. 8. 7 | S, Sandstrom T, Larsson K (2003): Obstructive Lung
81 II, 5. 8. 7 | Radon R, Jarvis D, Toren K, Künzli N, Norbäck D, d'
82 II, 5. 9. 7 | Compalati E, Penagos M, Henley K, Canonica GW (2007): Allergy
83 II, 5. 9. 7 | Custis N, Ronmark E, Wickens K, Sporik R, Woodfolk JA,
84 II, 5. 9. 7 | Gehring U, , Jacob B, Richter K, Fahlbusch B, Schlenvoigt
85 II, 5. 9. 7 | 108(1 Suppl):S2-8.~ ~Torén K (2004): A prospective study
86 II, 5. 10. 7 | Ballmer-Weber BK, Beyer K, Conti A, Dubakiene R, Fernandez-Rivas
87 II, 5. 10. 7 | M, Hoffmann-Sommergruber K, Lidholm J, Mustakov T,
88 II, 5. 10. 7 | Mackie AR, Burney P, Beyer K, Frewer L, Madsen C, Botjes
89 II, 5. 10. 7 | Sigurdardottir S, Lindner T, Goldhahn K, Dahlstrom J (2007): The
90 II, 5. 10. 7 | foodallergens.ifr.ac.uk~ ~Thomas K, Herouet-Guicheney C, Ladics
91 II, 5. 11. 3 | 25% in 1999 (C Lidén and K Norberg, 2005). In a study
92 II, 5. 11. 3 | IM Freedberg, AZ Eisen, K Wolff, KF Austen, LA Goldsmith,
93 II, 5. 11. 3 | Hasan T, Rantanen T, Alanko K, Harvima RJ, Jolanki R,
94 II, 5. 11. 3 | Harvima RJ, Jolanki R, Kalimo K, Lahti A, Lammintausta K,
95 II, 5. 11. 3 | K, Lahti A, Lammintausta K, Lauerma AI, Laukkanen A,
96 II, 5. 11. 3 | luukkaala T, Riekki R, Turjanmaa K, Varjonen E, Vuorela AM,
97 II, 5. 11. 3 | 2001:935–950.~C Lidén, K Norberg, Nickel on the Swedish
98 II, 5. 11. 7 | 2001;81:268–272.~ ~Weismann K, Krakauer R, Wanscher B (
99 II, 5. 12. 7 | Naveau S, Doffoel M, Boudjema K, Vanlemmens C, Mantion G,
100 II, 5. 15. 6 | Jul 7.~McCabe C, Claxton K, Tsuchiya A (2005): Orphan
101 II, 7. 7 | Organization, Peden M, McGee K, Sharma G.~ ~Racioppi F,
102 II, 8. 2. 1 | Research 51, 866-874.~Fisher, K., (2004). Health Disparities
103 II, 8. 2. 1 | 2008~Mason, J., & Scior, K., (2004). Diagnostic overshadowing
104 II, 8. 2. 1 | Luckasson, R.A. and Shogren K.A., With Borthwick-Duffy,
105 II, 8. 2. 3 | 13~ ~Uimonen S, Huttunen K, Jounio-Ervasti K, Sorri
106 II, 8. 2. 3 | Huttunen K, Jounio-Ervasti K, Sorri M (1999): Do we know
107 II, 9. 1. 1 | CV, Joseph KS, Demissie K, Vintzileos AM (2005): Trends
108 II, 9. 1. 1 | Alexander S, Wildman K, Zhang W, Langer M, Vutuc
109 II, 9. 1. 1 | 192.~Kramer MS, Demissie K, Yang H, Platt RW, Sauve
110 II, 9. 1. 1 | 63.~ ~Kramer MS, Demissie K, Yang H, Platt RW, Sauve
111 II, 9. 1. 1 | Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR (
112 II, 9. 1. 1 | 103.~ ~Zeitlin J, Wildman K, Breart G, Alexander S,
113 II, 9. 1. 2 | Vol 82, pp 349-352.~Waller K, Shaw GM, Rasmussen SA et
114 II, 9. 2. 7 | asp?intId=29].~ ~Matharu, K., Ozanne, S (2004): The
115 II, 9. 2. 7 | Ollila E, Lahtinen E, Leppo K (eds.) (2006): Health in
116 II, 9. 3. 1 | Brownhill S, Wilhelm K, Barclay L & Schmied V (
117 II, 9. 3. 1 | accessed 07.07)~ ~Fenton K A and Lowndes C M (2004):
118 II, 9. 3. 1 | 973-6~ ~Lee H, McGovern K, Finkelstein JS & Smith
119 II, 9. 3. 1 | 1516-23~ ~Makino M, Tsuboi K, Dennerstein L (2004); Prevalence
120 II, 9. 3. 1 | 3-6.~ ~White AK , Cash K (2003): The state of men’
121 II, 9. 3. 2 | Alexander S, Wildman K, Zhang W, Langer M, Vutuc
122 II, 9. 3. 2 | CV, Joseph KS, Demissie K, Vintzileos AM (2005): Trends
123 II, 9. 3. 2 | 192.~ ~Kramer MS, Demissie K, Yang H, Platt RW, Sauve
124 II, 9. 3. 2 | Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR (
125 II, 9. 3. 2 | 103.~ ~Zeitlin J, Wildman K, Breart G, Alexander S,
126 II, 9. 3. 3 | AM, Le Pont F, Wellings K, Spira A, Field J. (1995):
127 II, 9. 3. 3 | Hamers FF, Infuso A, Fenton K (2004) : Monitoring HIV/AIDS
128 II, 9. 3. 3 | Finland.~Herlitz C, Ramstedt K (2005): Assessment of sexual
129 II, 9. 3. 3 | Rodrigues LC, Wellings K, Weiss HA, Hayes R (2005):
130 II, 9. 3. 3 | McGee H, Qual A, Rundle K, Cousins G, Donnelly C,
131 II, 9. 3. 3 | 1998 and 2003.~Wellings K, Nanchahak K, Macdowall
132 II, 9. 3. 3 | 2003.~Wellings K, Nanchahak K, Macdowall W, McManus S,
133 II, 9. 3. 3 | 9296): 1843-1850.~Wellings K, Collumbien M, Slaymaker
134 II, 9. 4. 7 | Alaszewski A.M., Coxon K.; Summary (2004): Towards
135 II, 9. 5. 6 | caregiving. (Edited by: Willson K). Aurora, Ontario: Garamond
136 II, 9. 5. 6 | 28.~ ~Risberg G, Hamber K, Johansson E (2006): Gender
137 II, 9. 5. 6 | accessed 07.07)~ ~Stiehr K (2004): MERI: Mapping existing
138 III, 10. 1. 3 | Bull 114(2):376-90.~Melzer K, Kayser B, Saris WHM, Pichard
139 III, 10. 2. 1 | pdf~ ~Bates C, Fagerström K, Jarvis MJ, Kunze M, McNeill
140 III, 10. 2. 1 | 1207.~ ~Kunst AE, Giskes K, Mackenbach JP. Socioeconomic
141 III, 10. 2. 1 | Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Bofetta
142 III, 10. 2. 1 | Bohadana A, Fagerström K (2007): Introducing oral
143 III, 10. 2. 1 | G, Giesbrecht N, Graham K, Grube JW, Gruenewald PJ,
144 III, 10. 2. 1 | Stokes E, Sumnall H, Witty K, Bellis M (2007): A review
145 III, 10. 2. 1 | 49(3):131-133.~ ~Maxwell K, Tucker L (1992): Effects
146 III, 10. 2. 1 | 865.~ ~Popkin B M, Duffey K, Gordon-Larsen P (2005):
147 III, 10. 2. 1 | Information.~ ~Bayingana K, Demarest S, Gisle L, Hesse
148 III, 10. 2. 1 | Bromley C, Sproston K, Shelton N, eds (2005a):
149 III, 10. 2. 1 | Bromley C, Sproston K, Shelton N, eds (2005b):
150 III, 10. 2. 1 | Rolland-Cachera MF, Castetbon K, Arnault N, Bellisle F,
151 III, 10. 2. 1 | Oltarzewski M, Figurska K.): Warsaw, Prace IŻŻ 101;
152 III, 10. 2. 1 | Nutr. 4: 537-545.~ ~Kraemer K, Zimmermann MB (ed.). Nutritional
153 III, 10. 2. 1 | Spencer E, Stripp C, Overvad K, Clavel-Chapelon F, Casagrande
154 III, 10. 2. 1 | McTaggart A, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon
155 III, 10. 2. 1 | McTaggart A, Allen NE, Overvad K, Tjonneland A, Clavel-Chapelon
156 III, 10. 2. 1 | Welch A, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon
157 III, 10. 2. 1 | Miller AB, Schulz M, Botsi K, Naska A, Sieri S, Sacerdote
158 III, 10. 2. 1 | AA, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon
159 III, 10. 2. 1 | Miller AB, Klipstein-Grobusch K, Lagiou P, Kalapothaki V,
160 III, 10. 2. 1 | McTaggart A, Spencer EA, Overvad K, Tjonneland A, Stripp C,
161 III, 10. 2. 1 | Boeing H, Klipstein-Grobusch K, Trichopoulou A, Vasilopoulou
162 III, 10. 2. 1 | Kesse E, Klipstein-Grobusch K, San-Jose B, Welch AA, Krogh
163 III, 10. 2. 1 | Luben R, Allen N, Overvad K, Tjonneland A, Clavel-Chapelon
164 III, 10. 2. 1 | Luben R, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon
165 III, 10. 2. 1 | Linseisen J, Klipstein-Grobusch K, Benetou V, Zavitsanos X,
166 III, 10. 2. 4 | 61:466-471.~ ~Hoffmann K., Mattheisen M, Dahm S,
167 III, 10. 2. 4 | 1251.~ ~Ibarreta D, Bock, A.K., Klein C, Rodriguez-Cerezo
168 III, 10. 2. 4 | Warden DR, Smith D, Sleegens K, Prince JA, van Duijn CM,
169 III, 10. 2. 4 | Gómez-Barbero M, Stein A J, Bock A K (2007): Consequences, Opportunities
170 III, 10. 2. 5 | 50.~ ~Mäntymaa M, Puura K, Luoma I, Salmelin R, Davis
171 III, 10. 2. 5 | 2003;29(3):181-91.~ ~Puura K, Davis H, Papadopoulou K,
172 III, 10. 2. 5 | K, Davis H, Papadopoulou K, Tsiantis J, Ispanovic-Radojkovic
173 III, 10. 2. 5 | Available at http ~ ~Wahlbeck K, Forsen T, Osmond C, Barker
174 III, 10. 3. 1 | Stockholm, Sweden.~Leuraud K, Billon S, Bergot D, Tirmarche
175 III, 10. 3. 2 | 296: 199-208.~ ~Ravindra, K, L Bencs, R van Grieken (
176 III, 10. 4. 2 | Available at: htt ~ ~Inoue, K, Okada, F, Ito, R, Kato,
177 III, 10. 5. 1 | Walinder R, Gunnarsson K, Runeson R, Smedje G (2007)
178 IV, 11. 6. 5 | Research into Practice. K. Walshe and R. Boaden. Berkshire,
179 IV, 11. 6. 5 | Fund.~ ~Goldman M, Wood K (2007): European research
180 IV, 11. 6. 5 | Political Science.~ ~Hinrichs K (1997): Social Insurances
181 IV, 11. 6. 5 | Research into Practice. K. Walshe and R. Boaden. Berkshire,
182 IV, 11. 6. 5 | Organization.~ ~McGrail K, Green B et al. (2000): "
183 IV, 11. 6. 5 | 1601.~ ~Naylor CD, Iron K et al. (2002): Measuring
184 IV, 11. 6. 5 | Pharmacotherapy 26: 422-8.~ ~Taxis K, Barber N (2003): "Ethnographic
185 IV, 11. 6. 5 | Communities.~ ~van de Ven W, Beck K et al. (2003). "Risk adjustment
|
|
| |
